ArticleJAC-antimicrobial resistance2025
Development and assessment of the outpatient module of the Global-PPS: a standardized approach for measuring outpatient antimicrobial prescribing.
Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Using oral and parenteral formulation of AWaRe antibiotics as a proxy estimate of community and hospital healthcare sector use.JAC-antimicrobial resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Many tools for antimicrobial use surveillance have been exclusively developed for inpatient settings, although >80% of all antimicrobials are prescribed in outpatient care. In this study, we describe the methodology and first evaluation of the outpatient Global Point Prevalence Survey (Global-PPS). Methods: Global-PPS developed a standardized tool to measure outpatient antimicrobial prescribing patterns. A core set of variables was collected for all ambulatory patients, and more detailed data for those prescribed antimicrobials during the survey. A questionnaire containing 34 questions on experiences with the outpatient Global-PPS was administered to users who had used the outpatient module of the Global-PPS between May 2023 and December 2024. Results: In total, 39 (29.1%) participants of the outpatient Global-PPS from 25 (71.4%) different healthcare facilities responded to the questionnaire, of which 25 (from 16 facilities) completed it. Most respondents were from Nigeria (50%), Ghana (12.5%) or Guinea (10%).Respondent satisfaction was very high (>90%, Conclusions: The outpatient Global-PPS is the first freely available web-based standardized tool for measuring antimicrobial use in outpatient care worldwide, featuring an online data entry platform, validation and real-time reporting. This study confirmed a high degree of satisfaction among participants, although additional support is needed to train staff and overcome certain barriers, including access to patient information.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.